Search International and National Patent Collections

1. (WO2017153247) UTERINE CANCER TREATMENTS

Pub. No.:    WO/2017/153247    International Application No.:    PCT/EP2017/054908
Publication Date: Fri Sep 15 01:59:59 CEST 2017 International Filing Date: Fri Mar 03 00:59:59 CET 2017
IPC: A61K 38/17
A61K 39/00
C07K 7/06
C12N 5/0783
Applicants: IMMATICS BIOTECHNOLOGIES GMBH
Inventors: MAHR, Andrea
WEINSCHENK, Toni
SONG, Colette
SCHOOR, Oliver
FRITSCHE, Jens
SINGH, Harpreet
Title: UTERINE CANCER TREATMENTS
Abstract:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.